Literature DB >> 9394341

Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome.

F Schweda1, R Liebl, G A Riegger, B K Krämer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9394341     DOI: 10.1093/ndt/12.11.2433

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  10 in total

1.  Effective tacrolimus treatment in a child suffering from severe nephrotic syndrome.

Authors:  Marco Pennesi; Ambra Gagliardo; Silvia Minisini
Journal:  Pediatr Nephrol       Date:  2003-04-05       Impact factor: 3.714

2.  Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation.

Authors:  Yuko Osugi; Hiroshi Yamada; Gaku Hosoi; Haruyoshi Noma; Misako Ikemiya; Takefumi Ishii; Masahiro Sako
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

3.  Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial.

Authors:  Li Fan; Qinghua Liu; Yunhua Liao; Zhibin Li; Yulian Ji; Zhenhua Yang; Jian Chen; Junzhou Fu; Jinli Zhang; Yaozhong Kong; Ping Fu; Tanqi Lou; Zhengrong Liu; Xueqing Yu; Wei Chen
Journal:  Int Urol Nephrol       Date:  2012-06-09       Impact factor: 2.370

Review 4.  Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.

Authors:  Asha Moudgil; Arvind Bagga; Stanley C Jordan
Journal:  Pediatr Nephrol       Date:  2005-06-24       Impact factor: 3.714

5.  [Minimal Change Glomerulonephritis].

Authors:  S Stracke; U Helmchen; C Aymanns; N Kadlec; B Lindemann; S Hüttner; F Keller
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

6.  Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome.

Authors:  Kim Loeffler; Manjula Gowrishankar; Verna Yiu
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

7.  Population pharmacokinetics of tacrolimus in children with nephrotic syndrome.

Authors:  Guo-Xiang Hao; Xin Huang; Dong-Feng Zhang; Yi Zheng; Hai-Yan Shi; Yan Li; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2018-05-22       Impact factor: 4.335

Review 8.  History of Nephrotic Syndrome and Evolution of its Treatment.

Authors:  Abhijeet Pal; Frederick Kaskel
Journal:  Front Pediatr       Date:  2016-05-30       Impact factor: 3.418

Review 9.  Interventions for minimal change disease in adults with nephrotic syndrome.

Authors:  S C Palmer; K Nand; G F Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study.

Authors:  Yong Chul Kim; Tae Woo Lee; Hajeong Lee; Ho Suk Koo; Kook-Hwan Oh; Kwon Wook Joo; Suhnggwon Kim; Ho Jun Chin
Journal:  Kidney Res Clin Pract       Date:  2012-05-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.